Strong global surveillance from the WHO and CDC shows no novel pathogen with sustained human-to-human transmission or pandemic potential as of August 2026, keeping respiratory and zoonotic case counts at baseline seasonal levels. Enhanced post-COVID monitoring networks have enabled rapid detection of threats such as localized H5N1 avian influenza clusters, which lack the mutations needed for efficient spread. This data underpins the 94.5% market-implied probability of no new pandemic. Unexpected developments, including a high-transmissibility spillover event or significant viral evolution in circulating strains, remain possible but currently lack supporting epidemiological signals.